About Encube Ethicals Limited
What the company does and where it sits in its industry
INVESTORTRACK ANALYSISWe are a global pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms, serving 50 countries including regulated markets such as the United States, UK and Europe, and India.
We are a global pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms, serving 50 countries including regulated markets such as the United States, UK and Europe, and India as of March 31, 2026.
We operate through three business verticals: our global generics business, global contract development and manufacturing organization business and our India branded formulations business, each serving different end markets and customer segments supported by a unified platform of R&D, manufacturing infrastructure, quality management systems and supply chain.
With over 28 years of operations, we have built significant global scale in topical manufacturing and an aggregate installed filling and packaging capacity of 807 million units as of March 31, 2026 that corresponds to approximately 2.8 times the total US topical market demand in Fiscal 2026.
Main products & services
Topical pharmaceutical products including creams, lotions, gels, pastes, solutions, non-aerosol sprays, transdermal patches and hormone products.
Business model
Global pharmaceutical formulations platform operating across Global Generics, Global CDMO, and India Branded Formulations verticals.
Competitive positioning
Within six years of our entry in the US topical generics market, we have become the third largest player by volume with a market share of 12.18% in Fiscal 2026.